Concord Medical Services Holdings Limited

NYSE CCM

Concord Medical Services Holdings Limited Price to Sales Ratio (P/S) on December 30, 2024: 0.37

Concord Medical Services Holdings Limited Price to Sales Ratio (P/S) is 0.37 on December 30, 2024, a -6.90% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Concord Medical Services Holdings Limited 52-week high Price to Sales Ratio (P/S) is 0.80 on June 04, 2024, which is 114.83% above the current Price to Sales Ratio (P/S).
  • Concord Medical Services Holdings Limited 52-week low Price to Sales Ratio (P/S) is 0.03 on February 08, 2024, which is -92.02% below the current Price to Sales Ratio (P/S).
  • Concord Medical Services Holdings Limited average Price to Sales Ratio (P/S) for the last 52 weeks is 0.26.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
NYSE: CCM

Concord Medical Services Holdings Limited

CEO Dr. Jianyu Yang
IPO Date Dec. 11, 2009
Location China
Headquarters Tower A, Global Trade Center
Employees 727
Sector Health Care
Industries
Description

Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.

Similar companies

INNV

InnovAge Holding Corp.

USD 3.69

1.93%

EHC

Encompass Health Corporation

USD 93.06

0.54%

AMS

American Shared Hospital Services

USD 3.05

-0.33%

ENSG

The Ensign Group, Inc.

USD 133.50

0.88%

PNTG

The Pennant Group, Inc.

USD 26.51

1.07%

JYNT

The Joint Corp.

USD 10.22

-1.06%

SEM

Select Medical Holdings Corporation

USD 18.92

0.64%

EHAB

Enhabit, Inc.

USD 7.74

-0.39%

NHC

National HealthCare Corporation

USD 97.73

0.74%

SNDA

Sonida Senior Living, Inc.

USD 22.81

3.73%

StockViz Staff

January 15, 2025

Any question? Send us an email